💨 Abstract
The article primarily discusses the financial performance of Agenus Inc. (AGEN) for the first quarter of 2025. The biotechnology company reported a loss of $26.4 million, or $1.03 per share, which exceeded Wall Street expectations of a $1.61 per share loss. Revenue was $24.1 million, surpassing forecasts of $21 million.
Courtesy: wtop.com
Summarized by Einstein Beta 🤖
Suggested
Mexico says US suspension of beef imports because of screwworm is unfair -
Ringleader in Russian spy ring gets more than 10 years in UK prison -
Silvia Lospennato le responde a Milei: “Me da risa que se hable de un pacto entre Macri y Cristina” -
UK police investigate overnight fire that damaged door of house owned by Prime Minister Keir Starmer -
Celebrating Latin American Restaurant Weeks across the DC area -
Bright auroras on Jupiter are captured by Webb Space Telescope -
Bulgarian ringleader of Russian spy ring in the U.K. sentenced to more than 10 years in prison -
Pennsylvania Sportswatch Daily Listings -
Michigan Sportswatch Daily Listings -
Israeli official says Red Cross representatives are heading toward Khan Younis for handover of Israeli-American hostage -
Powered by MessengerX.io